Copyright
©The Author(s) 2017.
World J Gastrointest Surg. Feb 27, 2017; 9(2): 61-67
Published online Feb 27, 2017. doi: 10.4240/wjgs.v9.i2.61
Published online Feb 27, 2017. doi: 10.4240/wjgs.v9.i2.61
Factor | n (%) | Overall survival (mo) | P value |
Age (yr) | |||
< 40 | 16 (73) | 86 | |
≥ 40 | 6 (27) | 72 | 0.4 |
Gender | |||
Female | 11 (50) | 84 | |
Male | 11 (50) | 79 | 0.6 |
Tumor size (cm) | |||
< 10 | 8 (36) | 82 | |
≥ 10 | 14 (64) | 76 | 0.3 |
Number | |||
1 | 19 (86) | 89 | |
> 1 | 3 (14) | 77 | 0.2 |
Hepatic resection | |||
Hepatectomy | 16 (73) | 86 | |
Extended hepatectomy | 4 (18) | 77 | |
Localized resection | 2 (9) | 79 | 0.62 |
Nodal metastases | |||
Negative | 18 (82) | 88 | |
Positive | 4 (18) | 78 | 0.09 |
Vascular invasion | |||
Absent | 17 (77) | 92 | |
Present | 5 (23) | 58 | 0.03 |
Safety margin | |||
Negative | 20 (91) | 87 | |
Positive | 2 (9) | 72 | 0.08 |
- Citation: Wahab MA, El Hanafy E, El Nakeeb A, Ali MA. Clinicopathological features and surgical outcome of patients with fibrolamellar hepatocellular carcinoma (experience with 22 patients over a 15-year period). World J Gastrointest Surg 2017; 9(2): 61-67
- URL: https://www.wjgnet.com/1948-9366/full/v9/i2/61.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v9.i2.61